We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-0.37%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.43B
AUM Growth
-$12.4M
Cap. Flow
+$4.15M
Cap. Flow %
0.29%
Top 10 Hldgs %
31.81%
Holding
213
New
9
Increased
90
Reduced
54
Closed
8

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.73M
2
AZO icon
AutoZone
AZO
+$2.2M
3
MTB icon
M&T Bank
MTB
+$1.73M
4
HXL icon
Hexcel
HXL
+$1.65M
5
GILD icon
Gilead Sciences
GILD
+$934K

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$1.8M
2
MSFT icon
Microsoft
MSFT
+$1.75M
3
PYPL icon
PayPal
PYPL
+$1.41M
4
BC icon
Brunswick
BC
+$1.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 29.17%
2 Healthcare 14.99%
3 Financials 13.22%
4 Industrials 12.54%
5 Consumer Staples 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVV icon
101
iShares Core S&P 500 ETF
IVV
$871B
$970K 0.07%
2,250
+132
+6% +$58.5K
VEU icon
102
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$960K 0.07%
15,694
+94
+0.6% +$5.91K
VPL icon
103
Vanguard FTSE Pacific ETF
VPL
$7.89B
$960K 0.07%
11,825
– –
BMRN icon
104
BioMarin Pharmaceuticals
BMRN
$12B
$940K 0.07%
12,133
+399
+3% +$31.5K
J icon
105
Jacobs Solutions
J
$16.6B
$930K 0.06%
8,475
– –
MCD icon
106
McDonald's
MCD
$194B
$920K 0.06%
3,823
+421
+12% +$100K
PM icon
107
Philip Morris
PM
$312B
$910K 0.06%
9,561
– –
INCY icon
108
Incyte
INCY
$26B
$900K 0.06%
13,140
+280
+2% +$21.3K
AZN icon
109
AstraZeneca
AZN
$267B
$860K 0.06%
+7,135
New +$831K
WST icon
110
West Pharmaceutical
WST
$23.7B
$860K 0.06%
2,018
– –
CMCSA icon
111
Comcast
CMCSA
$85.8B
$840K 0.06%
15,103
+1,221
+9% +$71.2K
FUL icon
112
H.B. Fuller
FUL
$3.07B
$780K 0.05%
12,094
– –
NEE icon
113
NextEra Energy
NEE
$186B
$770K 0.05%
9,780
+2,208
+29% +$178K
BDX icon
114
Becton Dickinson
BDX
$45.8B
$750K 0.05%
3,127
+11
+0.4% +$2.7K
VHT icon
115
Vanguard Health Care ETF
VHT
$18.6B
$750K 0.05%
3,045
– –
IONS icon
116
Ionis Pharmaceuticals
IONS
$9.14B
$730K 0.05%
21,691
+638
+3% +$24K
LLY icon
117
Eli Lilly
LLY
$1.09T
$710K 0.05%
3,071
– –
T icon
118
AT&T
T
$169B
$710K 0.05%
34,882
-1,630
-4% -$34.2K
IBM icon
119
IBM
IBM
$214B
$680K 0.05%
5,111
+209
+4% +$27.9K
BP icon
120
BP
BP
$107B
$640K 0.04%
23,479
-846
-3% -$21.2K
NVO
121
Novo Nordisk
NVO
$225B
$640K 0.04%
13,434
+1,100
+9% +$53.2K
OGN icon
122
Organon & Co
OGN
$3.55B
$610K 0.04%
18,516
-11,269
-38% -$361K
ABBV icon
123
AbbVie
ABBV
$465B
$600K 0.04%
5,583
+300
+6% +$34.3K
HUBB icon
124
Hubbell
HUBB
$25.6B
$600K 0.04%
3,308
– –
CSCO icon
125
Cisco
CSCO
$456B
$570K 0.04%
10,386
+2,849
+38% +$160K
3 4
5
6 7

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q3 2021 Portfolio in Review

As of Q3 2021, Grandfield & Dodd held 213 positions worth $1.43B, down 0.86% from $1.45B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q3 2021 filing shows 9 new, 90 increased, 54 reduced and 8 closed positions. Its largest new stake was AutoZone: 1,373 shares worth $2.33M. The largest sale was eBay, an estimated $1.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2021 buy was AutoZone: 1,373 shares worth $2.33M.
  • Grandfield & Dodd added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $2.73M increase.
  • Grandfield & Dodd's biggest Q3 2021 reduction was eBay, cutting an estimated $1.8M.
  • Grandfield & Dodd fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.29M.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.43B portfolio in Q3 2021.
  • Grandfield & Dodd opened 9 new positions and closed 8 in Q3 2021.
  • Grandfield & Dodd's portfolio value fell 0.86% quarter-over-quarter to $1.43B.

Based on Grandfield & Dodd's 13F filing for Q3 2021, filed 28 Oct 2021.